Bill Text: IL SB3275 | 2013-2014 | 98th General Assembly | Introduced
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Amends the Illinois Controlled Substances Act. Adds 25I-NBOMe to the list of Schedule I controlled substances.
Spectrum: Slight Partisan Bill (Republican 5-2)
Status: (Passed) 2014-08-18 - Public Act . . . . . . . . . 98-0987 [SB3275 Detail]
Download: Illinois-2013-SB3275-Introduced.html
Bill Title: Amends the Illinois Controlled Substances Act. Adds 25I-NBOMe to the list of Schedule I controlled substances.
Spectrum: Slight Partisan Bill (Republican 5-2)
Status: (Passed) 2014-08-18 - Public Act . . . . . . . . . 98-0987 [SB3275 Detail]
Download: Illinois-2013-SB3275-Introduced.html
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
1 | AN ACT concerning criminal law.
| ||||||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||
3 | represented in the General Assembly:
| ||||||||||||||||||||||||
4 | Section 5. The Illinois Controlled Substances Act is | ||||||||||||||||||||||||
5 | amended by changing Section 204 as follows:
| ||||||||||||||||||||||||
6 | (720 ILCS 570/204) (from Ch. 56 1/2, par. 1204) | ||||||||||||||||||||||||
7 | Sec. 204. (a) The controlled substances listed in this | ||||||||||||||||||||||||
8 | Section are
included in Schedule I. | ||||||||||||||||||||||||
9 | (b) Unless specifically excepted or unless listed in | ||||||||||||||||||||||||
10 | another
schedule, any of the following opiates, including their | ||||||||||||||||||||||||
11 | isomers,
esters, ethers, salts, and salts of isomers, esters, | ||||||||||||||||||||||||
12 | and ethers,
whenever the existence of such isomers, esters, | ||||||||||||||||||||||||
13 | ethers and salts is
possible within the specific chemical | ||||||||||||||||||||||||
14 | designation: | ||||||||||||||||||||||||
15 | (1) Acetylmethadol; | ||||||||||||||||||||||||
16 | (1.1) Acetyl-alpha-methylfentanyl | ||||||||||||||||||||||||
17 | (N-[1-(1-methyl-2-phenethyl)-
| ||||||||||||||||||||||||
18 | 4-piperidinyl]-N-phenylacetamide); | ||||||||||||||||||||||||
19 | (2) Allylprodine; | ||||||||||||||||||||||||
20 | (3) Alphacetylmethadol, except
| ||||||||||||||||||||||||
21 | levo-alphacetylmethadol (also known as levo-alpha-
| ||||||||||||||||||||||||
22 | acetylmethadol, levomethadyl acetate, or LAAM); | ||||||||||||||||||||||||
23 | (4) Alphameprodine; |
| |||||||
| |||||||
1 | (5) Alphamethadol; | ||||||
2 | (6) Alpha-methylfentanyl
| ||||||
3 | (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
| ||||||
4 | propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
| ||||||
5 | propanilido) piperidine; | ||||||
6 | (6.1) Alpha-methylthiofentanyl
| ||||||
7 | (N-[1-methyl-2-(2-thienyl)ethyl-
| ||||||
8 | 4-piperidinyl]-N-phenylpropanamide); | ||||||
9 | (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP); | ||||||
10 | (7.1) PEPAP
| ||||||
11 | (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine); | ||||||
12 | (8) Benzethidine; | ||||||
13 | (9) Betacetylmethadol; | ||||||
14 | (9.1) Beta-hydroxyfentanyl
| ||||||
15 | (N-[1-(2-hydroxy-2-phenethyl)-
| ||||||
16 | 4-piperidinyl]-N-phenylpropanamide); | ||||||
17 | (10) Betameprodine; | ||||||
18 | (11) Betamethadol; | ||||||
19 | (12) Betaprodine; | ||||||
20 | (13) Clonitazene; | ||||||
21 | (14) Dextromoramide; | ||||||
22 | (15) Diampromide; | ||||||
23 | (16) Diethylthiambutene; | ||||||
24 | (17) Difenoxin; | ||||||
25 | (18) Dimenoxadol; | ||||||
26 | (19) Dimepheptanol; |
| |||||||
| |||||||
1 | (20) Dimethylthiambutene; | ||||||
2 | (21) Dioxaphetylbutyrate; | ||||||
3 | (22) Dipipanone; | ||||||
4 | (23) Ethylmethylthiambutene; | ||||||
5 | (24) Etonitazene; | ||||||
6 | (25) Etoxeridine; | ||||||
7 | (26) Furethidine; | ||||||
8 | (27) Hydroxpethidine; | ||||||
9 | (28) Ketobemidone; | ||||||
10 | (29) Levomoramide; | ||||||
11 | (30) Levophenacylmorphan; | ||||||
12 | (31) 3-Methylfentanyl
| ||||||
13 | (N-[3-methyl-1-(2-phenylethyl)-
| ||||||
14 | 4-piperidyl]-N-phenylpropanamide); | ||||||
15 | (31.1) 3-Methylthiofentanyl
| ||||||
16 | (N-[(3-methyl-1-(2-thienyl)ethyl-
| ||||||
17 | 4-piperidinyl]-N-phenylpropanamide); | ||||||
18 | (32) Morpheridine; | ||||||
19 | (33) Noracymethadol; | ||||||
20 | (34) Norlevorphanol; | ||||||
21 | (35) Normethadone; | ||||||
22 | (36) Norpipanone; | ||||||
23 | (36.1) Para-fluorofentanyl
| ||||||
24 | (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
| ||||||
25 | 4-piperidinyl]propanamide); | ||||||
26 | (37) Phenadoxone; |
| |||||||
| |||||||
1 | (38) Phenampromide; | ||||||
2 | (39) Phenomorphan; | ||||||
3 | (40) Phenoperidine; | ||||||
4 | (41) Piritramide; | ||||||
5 | (42) Proheptazine; | ||||||
6 | (43) Properidine; | ||||||
7 | (44) Propiram; | ||||||
8 | (45) Racemoramide; | ||||||
9 | (45.1) Thiofentanyl
| ||||||
10 | (N-phenyl-N-[1-(2-thienyl)ethyl-
| ||||||
11 | 4-piperidinyl]-propanamide); | ||||||
12 | (46) Tilidine; | ||||||
13 | (47) Trimeperidine; | ||||||
14 | (48) Beta-hydroxy-3-methylfentanyl (other name:
| ||||||
15 | N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
| ||||||
16 | N-phenylpropanamide). | ||||||
17 | (c) Unless specifically excepted or unless listed in | ||||||
18 | another
schedule, any of the following opium derivatives, its | ||||||
19 | salts, isomers
and salts of isomers, whenever the existence of | ||||||
20 | such salts, isomers and
salts of isomers is possible within the | ||||||
21 | specific chemical designation: | ||||||
22 | (1) Acetorphine; | ||||||
23 | (2) Acetyldihydrocodeine; | ||||||
24 | (3) Benzylmorphine; | ||||||
25 | (4) Codeine methylbromide; | ||||||
26 | (5) Codeine-N-Oxide; |
| |||||||
| |||||||
1 | (6) Cyprenorphine; | ||||||
2 | (7) Desomorphine; | ||||||
3 | (8) Diacetyldihydromorphine (Dihydroheroin); | ||||||
4 | (9) Dihydromorphine; | ||||||
5 | (10) Drotebanol; | ||||||
6 | (11) Etorphine (except hydrochloride salt); | ||||||
7 | (12) Heroin; | ||||||
8 | (13) Hydromorphinol; | ||||||
9 | (14) Methyldesorphine; | ||||||
10 | (15) Methyldihydromorphine; | ||||||
11 | (16) Morphine methylbromide; | ||||||
12 | (17) Morphine methylsulfonate; | ||||||
13 | (18) Morphine-N-Oxide; | ||||||
14 | (19) Myrophine; | ||||||
15 | (20) Nicocodeine; | ||||||
16 | (21) Nicomorphine; | ||||||
17 | (22) Normorphine; | ||||||
18 | (23) Pholcodine; | ||||||
19 | (24) Thebacon. | ||||||
20 | (d) Unless specifically excepted or unless listed in | ||||||
21 | another
schedule, any material, compound, mixture, or | ||||||
22 | preparation which contains
any quantity of the following | ||||||
23 | hallucinogenic substances, or which
contains any of its salts, | ||||||
24 | isomers and salts of isomers, whenever the
existence of such | ||||||
25 | salts, isomers, and salts of isomers is possible
within the | ||||||
26 | specific chemical designation (for the purposes of this
|
| |||||||
| |||||||
1 | paragraph only, the term "isomer" includes the optical, | ||||||
2 | position and
geometric isomers): | ||||||
3 | (1) 3,4-methylenedioxyamphetamine
| ||||||
4 | (alpha-methyl,3,4-methylenedioxyphenethylamine,
| ||||||
5 | methylenedioxyamphetamine, MDA); | ||||||
6 | (1.1) Alpha-ethyltryptamine
| ||||||
7 | (some trade or other names: etryptamine;
| ||||||
8 | MONASE; alpha-ethyl-1H-indole-3-ethanamine;
| ||||||
9 | 3-(2-aminobutyl)indole; a-ET; and AET); | ||||||
10 | (2) 3,4-methylenedioxymethamphetamine (MDMA); | ||||||
11 | (2.1) 3,4-methylenedioxy-N-ethylamphetamine
| ||||||
12 | (also known as: N-ethyl-alpha-methyl-
| ||||||
13 | 3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
| ||||||
14 | and MDEA); | ||||||
15 | (2.2) N-Benzylpiperazine (BZP); | ||||||
16 | (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA); | ||||||
17 | (4) 3,4,5-trimethoxyamphetamine (TMA); | ||||||
18 | (5) (Blank); | ||||||
19 | (6) Diethyltryptamine (DET); | ||||||
20 | (7) Dimethyltryptamine (DMT); | ||||||
21 | (7.1) 5-Methoxy-diallyltryptamine; | ||||||
22 | (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP); | ||||||
23 | (9) Ibogaine (some trade and other names:
| ||||||
24 | 7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
| ||||||
25 | 6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
| ||||||
26 | indole; Tabernanthe iboga); |
| |||||||
| |||||||
1 | (10) Lysergic acid diethylamide; | ||||||
2 | (10.1) Salvinorin A; | ||||||
3 | (10.5) Salvia divinorum (meaning all parts of the plant | ||||||
4 | presently classified
botanically as Salvia divinorum, | ||||||
5 | whether growing or not, the
seeds thereof, any extract from | ||||||
6 | any part of that plant, and every compound,
manufacture, | ||||||
7 | salts, isomers, and salts of
isomers whenever the existence | ||||||
8 | of such salts, isomers, and salts of
isomers is possible | ||||||
9 | within the specific chemical designation, derivative, | ||||||
10 | mixture, or preparation of that plant, its
seeds or | ||||||
11 | extracts);
| ||||||
12 | (11) 3,4,5-trimethoxyphenethylamine (Mescaline); | ||||||
13 | (12) Peyote (meaning all parts of the plant presently | ||||||
14 | classified
botanically as Lophophora williamsii
Lemaire, | ||||||
15 | whether growing or not, the
seeds thereof, any extract from | ||||||
16 | any part of that plant, and every compound,
manufacture, | ||||||
17 | salts, derivative, mixture, or preparation of that plant, | ||||||
18 | its
seeds or extracts); | ||||||
19 | (13) N-ethyl-3-piperidyl benzilate (JB 318); | ||||||
20 | (14) N-methyl-3-piperidyl benzilate; | ||||||
21 | (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
| ||||||
22 | (also known as N-hydroxy-alpha-methyl-
| ||||||
23 | 3,4(methylenedioxy)phenethylamine and N-hydroxy MDA); | ||||||
24 | (15) Parahexyl; some trade or other names:
| ||||||
25 | 3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
| ||||||
26 | dibenzo (b,d) pyran; Synhexyl; |
| |||||||
| |||||||
1 | (16) Psilocybin; | ||||||
2 | (17) Psilocyn; | ||||||
3 | (18) Alpha-methyltryptamine (AMT); | ||||||
4 | (19) 2,5-dimethoxyamphetamine
| ||||||
5 | (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA); | ||||||
6 | (20) 4-bromo-2,5-dimethoxyamphetamine
| ||||||
7 | (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
| ||||||
8 | 4-bromo-2,5-DMA); | ||||||
9 | (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
| ||||||
10 | Some trade or other names: 2-(4-bromo-
| ||||||
11 | 2,5-dimethoxyphenyl)-1-aminoethane;
| ||||||
12 | alpha-desmethyl DOB, 2CB, Nexus; | ||||||
13 | (21) 4-methoxyamphetamine
| ||||||
14 | (4-methoxy-alpha-methylphenethylamine;
| ||||||
15 | paramethoxyamphetamine; PMA); | ||||||
16 | (22) (Blank); | ||||||
17 | (23) Ethylamine analog of phencyclidine.
| ||||||
18 | Some trade or other names:
| ||||||
19 | N-ethyl-1-phenylcyclohexylamine,
| ||||||
20 | (1-phenylcyclohexyl) ethylamine,
| ||||||
21 | N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE; | ||||||
22 | (24) Pyrrolidine analog of phencyclidine. Some trade | ||||||
23 | or other names:
1-(1-phenylcyclohexyl) pyrrolidine, PCPy, | ||||||
24 | PHP; | ||||||
25 | (25) 5-methoxy-3,4-methylenedioxy-amphetamine; | ||||||
26 | (26) 2,5-dimethoxy-4-ethylamphetamine
|
| |||||||
| |||||||
1 | (another name: DOET); | ||||||
2 | (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
| ||||||
3 | (another name: TCPy); | ||||||
4 | (28) (Blank); | ||||||
5 | (29) Thiophene analog of phencyclidine (some trade
| ||||||
6 | or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
| ||||||
7 | 2-thienyl analog of phencyclidine; TPCP; TCP); | ||||||
8 | (30) Bufotenine (some trade or other names:
| ||||||
9 | 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
| ||||||
10 | 3-(2-dimethylaminoethyl)-5-indolol;
| ||||||
11 | 5-hydroxy-N,N-dimethyltryptamine;
| ||||||
12 | N,N-dimethylserotonin; mappine); | ||||||
13 | (31) 1-Pentyl-3-(1-naphthoyl)indole | ||||||
14 | Some trade or other names: JWH-018; | ||||||
15 | (32) 1-Butyl-3-(1-naphthoyl)indole | ||||||
16 | Some trade or other names: JWH-073; | ||||||
17 | (33) 1-[(5-fluoropentyl)-1H-indol-3-yl]- | ||||||
18 | (2-iodophenyl)methanone | ||||||
19 | Some trade or other names: AM-694; | ||||||
20 | (34) 2-[(1R,3S)-3-hydroxycyclohexyl]-5- | ||||||
21 | (2-methyloctan-2-yl)phenol | ||||||
22 | Some trade or other names: CP 47,497 | ||||||
23 | and its C6, C8 and C9 homologs; | ||||||
24 | (34.5) 2-[(1R,3S)-3-hydroxycyclohexyl]-5- | ||||||
25 | (2-methyloctan-2-yl)phenol), where side chain n=5; | ||||||
26 | and homologues where side chain n=4, 6, or 7; Some |
| |||||||
| |||||||
1 | trade or other names: CP 47,497; | ||||||
2 | (35) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3- | ||||||
3 | (2-methyloctan-2-yl)-6a,7, | ||||||
4 | 10,10a-tetrahydrobenzo[c]chromen-1-ol | ||||||
5 | Some trade or other names: HU-210; | ||||||
6 | (35.5) (6aS,10aS)-9-(hydroxymethyl)-6,6- | ||||||
7 | dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- | ||||||
8 | tetrahydrobenzo[c]chromen-1-ol, its isomers, | ||||||
9 | salts, and salts of isomers; Some trade or other | ||||||
10 | names: HU-210, Dexanabinol; | ||||||
11 | (36) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)- | ||||||
12 | 6,6-dimethyl-3-(2-methyloctan-2-yl)- | ||||||
13 | 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | ||||||
14 | Some trade or other names: HU-211; | ||||||
15 | (37) (2-methyl-1-propyl-1H-indol- | ||||||
16 | 3-yl)-1-naphthalenyl-methanone | ||||||
17 | Some trade or other names: JWH-015; | ||||||
18 | (38) 4-methoxynaphthalen-1-yl- | ||||||
19 | (1-pentylindol-3-yl)methanone | ||||||
20 | Some trade or other names: JWH-081; | ||||||
21 | (39) 1-Pentyl-3-(4-methyl-1-naphthoyl)indole | ||||||
22 | Some trade or other names: JWH-122; | ||||||
23 | (40) 2-(2-methylphenyl)-1-(1-pentyl- | ||||||
24 | 1H-indol-3-yl)-ethanone | ||||||
25 | Some trade or other names: JWH-251; | ||||||
26 | (41) 1-(2-cyclohexylethyl)-3- |
| |||||||
| |||||||
1 | (2-methoxyphenylacetyl)indole | ||||||
2 | Some trade or other names: RCS-8, BTW-8 and SR-18; | ||||||
3 | (42) Any compound structurally derived from | ||||||
4 | 3-(1-naphthoyl)indole or 1H-indol-3-yl- | ||||||
5 | (1-naphthyl)methane by substitution at the | ||||||
6 | nitrogen atom of the indole ring by alkyl, haloalkyl, | ||||||
7 | alkenyl, cycloalkylmethyl, cycloalkylethyl or | ||||||
8 | 2-(4-morpholinyl)ethyl whether or not further | ||||||
9 | substituted in the indole ring to any extent, whether | ||||||
10 | or not substituted in the naphthyl ring to any extent; | ||||||
11 | (43) Any compound structurally derived from | ||||||
12 | 3-(1-naphthoyl)pyrrole by substitution at the nitrogen | ||||||
13 | atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, | ||||||
14 | cycloalkylmethyl, cycloalkylethyl or | ||||||
15 | 2-(4-morpholinyl)ethyl, whether or not further | ||||||
16 | substituted in the pyrrole ring to any extent, whether | ||||||
17 | or not substituted in the naphthyl ring to any extent; | ||||||
18 | (44) Any compound structurally derived from | ||||||
19 | 1-(1-naphthylmethyl)indene by substitution | ||||||
20 | at the 3-position of the indene ring by alkyl, haloalkyl, | ||||||
21 | alkenyl, cycloalkylmethyl, cycloalkylethyl or | ||||||
22 | 2-(4-morpholinyl)ethyl whether or not further | ||||||
23 | substituted in the indene ring to any extent, whether | ||||||
24 | or not substituted in the naphthyl ring to any extent; | ||||||
25 | (45) Any compound structurally derived from | ||||||
26 | 3-phenylacetylindole by substitution at the |
| |||||||
| |||||||
1 | nitrogen atom of the indole ring with alkyl, haloalkyl, | ||||||
2 | alkenyl, cycloalkylmethyl, cycloalkylethyl or | ||||||
3 | 2-(4-morpholinyl)ethyl, whether or not further | ||||||
4 | substituted in the indole ring to any extent, whether | ||||||
5 | or not substituted in the phenyl ring to any extent; | ||||||
6 | (46) Any compound structurally derived from | ||||||
7 | 2-(3-hydroxycyclohexyl)phenol by substitution | ||||||
8 | at the 5-position of the phenolic ring by alkyl, | ||||||
9 | haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl | ||||||
10 | or 2-(4-morpholinyl)ethyl, whether or not substituted | ||||||
11 | in the cyclohexyl ring to any extent; | ||||||
12 | (47) 3,4-Methylenedioxymethcathinone | ||||||
13 | Some trade or other names: Methylone; | ||||||
14 | (48) 3,4-Methyenedioxypyrovalerone | ||||||
15 | Some trade or other names: MDPV; | ||||||
16 | (49) 4-Methylmethcathinone | ||||||
17 | Some trade or other names: Mephedrone; | ||||||
18 | (50) 4-methoxymethcathinone; | ||||||
19 | (51) 4-Fluoromethcathinone; | ||||||
20 | (52) 3-Fluoromethcathinone; | ||||||
21 | (53) 2,5-Dimethoxy-4-(n)-propylthio- | ||||||
22 | phenethylamine; | ||||||
23 | (54) 5-Methoxy-N,N-diisopropyltryptamine; | ||||||
24 | (55) Pentedrone ; . | ||||||
25 | (56) 4-iodo-2,5-dimethoxy-N-((2-methoxy | ||||||
26 | phenyl)methyl)-benzeneethanamine |
| |||||||
| |||||||
1 | (trade or other name: 25I-NBOMe). | ||||||
2 | (e) Unless specifically excepted or unless listed in | ||||||
3 | another
schedule, any material, compound, mixture, or | ||||||
4 | preparation which contains
any quantity of the following | ||||||
5 | substances having a depressant effect on
the central nervous | ||||||
6 | system, including its salts, isomers, and salts of
isomers | ||||||
7 | whenever the existence of such salts, isomers, and salts of
| ||||||
8 | isomers is possible within the specific chemical designation: | ||||||
9 | (1) mecloqualone; | ||||||
10 | (2) methaqualone; and | ||||||
11 | (3) gamma hydroxybutyric acid. | ||||||
12 | (f) Unless specifically excepted or unless listed in | ||||||
13 | another schedule,
any material, compound, mixture, or | ||||||
14 | preparation which contains any quantity
of the following | ||||||
15 | substances having a stimulant effect on the central nervous
| ||||||
16 | system, including its salts, isomers, and salts of isomers: | ||||||
17 | (1) Fenethylline; | ||||||
18 | (2) N-ethylamphetamine; | ||||||
19 | (3) Aminorex (some other names:
| ||||||
20 | 2-amino-5-phenyl-2-oxazoline; aminoxaphen;
| ||||||
21 | 4-5-dihydro-5-phenyl-2-oxazolamine) and its
| ||||||
22 | salts, optical isomers, and salts of optical isomers; | ||||||
23 | (4) Methcathinone (some other names:
| ||||||
24 | 2-methylamino-1-phenylpropan-1-one;
| ||||||
25 | Ephedrone; 2-(methylamino)-propiophenone;
| ||||||
26 | alpha-(methylamino)propiophenone; N-methylcathinone;
|
| |||||||
| |||||||
1 | methycathinone; Monomethylpropion; UR 1431) and its
| ||||||
2 | salts, optical isomers, and salts of optical isomers; | ||||||
3 | (5) Cathinone (some trade or other names:
| ||||||
4 | 2-aminopropiophenone; alpha-aminopropiophenone;
| ||||||
5 | 2-amino-1-phenyl-propanone; norephedrone); | ||||||
6 | (6) N,N-dimethylamphetamine (also known as:
| ||||||
7 | N,N-alpha-trimethyl-benzeneethanamine;
| ||||||
8 | N,N-alpha-trimethylphenethylamine); | ||||||
9 | (7) (+ or -) cis-4-methylaminorex ((+ or -) cis-
| ||||||
10 | 4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine); | ||||||
11 | (8) 3,4-Methylenedioxypyrovalerone (MDPV). | ||||||
12 | (g) Temporary listing of substances subject to emergency | ||||||
13 | scheduling.
Any material, compound, mixture, or preparation | ||||||
14 | that contains any quantity
of the following substances: | ||||||
15 | (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
| ||||||
16 | (benzylfentanyl), its optical isomers, isomers, salts,
| ||||||
17 | and salts of isomers; | ||||||
18 | (2) N-[1(2-thienyl)
| ||||||
19 | methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
| ||||||
20 | its optical isomers, salts, and salts of isomers. | ||||||
21 | (Source: P.A. 96-347, eff. 1-1-10; 96-1285, eff. 1-1-11; | ||||||
22 | 97-192, eff. 7-22-11; 97-193, eff. 1-1-12; 97-194, eff. | ||||||
23 | 7-22-11; 97-334, eff. 1-1-12; 97-813, eff. 7-13-12; 97-872, | ||||||
24 | eff. 7-31-12.)
|